Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial
Titel:
Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial
Auteur:
Bellmunt, Joaquim Hussain, Maha Gschwend, Jürgen E Albers, Peter Oudard, Stephane Castellano, Daniel Daneshmand, Siamak Nishiyama, Hiroyuki Majchrowicz, Martin Degaonkar, Viraj Shi, Yi Mariathasan, Sanjeev Grivas, Petros Drakaki, Alexandra O'Donnell, Peter H Rosenberg, Jonathan E Geynisman, Daniel M Petrylak, Daniel P Hoffman-Censits, Jean Bedke, Jens Kalebasty, Arash Rezazadeh Zakharia, Yousef van der Heijden, Michiel S Sternberg, Cora N Davarpanah, Nicole N Powles, Thomas